BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy15668
(365 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1EZQ|B Chain B, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|B Chain B, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|B Chain B, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|B Chain B, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFW|B Chain B, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|B Chain B, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|B Chain B, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|A Chain A, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|A Chain A, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|A Chain A, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|A Chain A, Crystal Structure Of Fxa In Complex With 45.
pdb|2BOH|A Chain A, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|B Chain B, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|B Chain B, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|B Chain B, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|B Chain B, Factor Xa Inhibitor Complex
pdb|2VH0|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|B Chain B, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|B Chain B, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
Length = 134
Score = 31.2 bits (69), Expect = 0.98, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 32/94 (34%), Gaps = 22/94 (23%)
Query: 4 YMGGDPCSPNPCGSNTQCNVASNRPVCSCLPGHWGNPLTYCQRGECQ-DHSDCSHSKACK 62
Y GD C +PC + +C C+CL G G R C D+ DC
Sbjct: 39 YKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQF---- 94
Query: 63 EYRCVDVCAGQCGVNSECNVRNHIPVCSCPPGYT 96
C+ + VCSC GYT
Sbjct: 95 -----------------CHEEQNSVVCSCARGYT 111
Score = 27.7 bits (60), Expect = 9.9, Method: Compositional matrix adjust.
Identities = 22/75 (29%), Positives = 29/75 (38%), Gaps = 6/75 (8%)
Query: 285 YQNNKTIFYVSLVSLNYPYVTPLPDDLCEPNPCGENAKCQPGYDKSGKDRPVCTCLPGYV 344
Y+ + +F S + N + D CE +PC KC K G CTCL G+
Sbjct: 19 YEEAREVFEDSDKT-NEFWNKYKDGDQCETSPCQNQGKC-----KDGLGEYTCTCLEGFE 72
Query: 345 GDALTYCRRGECQSD 359
G R C D
Sbjct: 73 GKNCELFTRKLCSLD 87
>pdb|1IOE|L Chain L, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|L Chain L, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|L Chain L, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|L Chain L, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|L Chain L, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|L Chain L, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|L Chain L, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|L Chain L, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|L Chain L, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|L Chain L, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|L Chain L, Human Coagulation Factor Xa In Complex With M55192
pdb|1C5M|F Chain F, Structural Basis For Selectivity Of A Small Molecule,
S1- Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|4A7I|A Chain A, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 96
Score = 30.8 bits (68), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 32/94 (34%), Gaps = 22/94 (23%)
Query: 4 YMGGDPCSPNPCGSNTQCNVASNRPVCSCLPGHWGNPLTYCQRGECQ-DHSDCSHSKACK 62
Y GD C +PC + +C C+CL G G R C D+ DC
Sbjct: 1 YKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQF---- 56
Query: 63 EYRCVDVCAGQCGVNSECNVRNHIPVCSCPPGYT 96
C+ + VCSC GYT
Sbjct: 57 -----------------CHEEQNSVVCSCARGYT 73
>pdb|1P0S|L Chain L, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
Length = 138
Score = 30.4 bits (67), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 32/94 (34%), Gaps = 22/94 (23%)
Query: 4 YMGGDPCSPNPCGSNTQCNVASNRPVCSCLPGHWGNPLTYCQRGECQ-DHSDCSHSKACK 62
Y GD C +PC + +C C+CL G G R C D+ DC
Sbjct: 44 YKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQF---- 99
Query: 63 EYRCVDVCAGQCGVNSECNVRNHIPVCSCPPGYT 96
C+ + VCSC GYT
Sbjct: 100 -----------------CHEEQNSVVCSCARGYT 116
>pdb|1FAX|L Chain L, Coagulation Factor Xa Inhibitor Complex
Length = 96
Score = 30.0 bits (66), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 31/94 (32%), Gaps = 22/94 (23%)
Query: 4 YMGGDPCSPNPCGSNTQCNVASNRPVCSCLPGHWGNPLTYCQRGECQ-DHSDCSHSKACK 62
Y GD C +PC + +C C+CL G G R C D+ DC
Sbjct: 1 YKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQF---- 56
Query: 63 EYRCVDVCAGQCGVNSECNVRNHIPVCSCPPGYT 96
C+ VCSC GYT
Sbjct: 57 -----------------CHEEQASVVCSCARGYT 73
>pdb|1NFU|B Chain B, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
Length = 195
Score = 30.0 bits (66), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 32/94 (34%), Gaps = 22/94 (23%)
Query: 4 YMGGDPCSPNPCGSNTQCNVASNRPVCSCLPGHWGNPLTYCQRGECQ-DHSDCSHSKACK 62
Y GD C +PC + +C C+CL G G R C D+ DC
Sbjct: 39 YKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQF---- 94
Query: 63 EYRCVDVCAGQCGVNSECNVRNHIPVCSCPPGYT 96
C+ + VCSC GYT
Sbjct: 95 -----------------CHEEQNSVVCSCARGYT 111
>pdb|1XKA|L Chain L, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|A Chain A, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|B Chain B, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1WU1|B Chain B, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
Length = 95
Score = 29.3 bits (64), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 31/91 (34%), Gaps = 22/91 (24%)
Query: 7 GDPCSPNPCGSNTQCNVASNRPVCSCLPGHWGNPLTYCQRGECQ-DHSDCSHSKACKEYR 65
GD C +PC + +C C+CL G G R C D+ DC
Sbjct: 3 GDQCETSPCQNQGKCKXGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQF------- 55
Query: 66 CVDVCAGQCGVNSECNVRNHIPVCSCPPGYT 96
C+ + VCSC GYT
Sbjct: 56 --------------CHEEQNSVVCSCARGYT 72
>pdb|3ENS|A Chain A, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-
(2-oxo-2-
Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|C Chain C, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-
(2-oxo-2-
Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|A Chain A, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|C Chain C, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|A Chain A, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2-
Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|C Chain C, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2-
Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|A Chain A, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 94
Score = 28.9 bits (63), Expect = 5.3, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 31/91 (34%), Gaps = 22/91 (24%)
Query: 7 GDPCSPNPCGSNTQCNVASNRPVCSCLPGHWGNPLTYCQRGECQ-DHSDCSHSKACKEYR 65
GD C +PC + +C C+CL G G R C D+ DC
Sbjct: 3 GDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQF------- 55
Query: 66 CVDVCAGQCGVNSECNVRNHIPVCSCPPGYT 96
C+ + VCSC GYT
Sbjct: 56 --------------CHEEQNSVVCSCARGYT 72
>pdb|1G2L|B Chain B, Factor Xa Inhibitor Complex
pdb|1G2M|B Chain B, Factor Xa Inhibitor Complex
Length = 94
Score = 28.5 bits (62), Expect = 5.5, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 31/91 (34%), Gaps = 22/91 (24%)
Query: 7 GDPCSPNPCGSNTQCNVASNRPVCSCLPGHWGNPLTYCQRGECQ-DHSDCSHSKACKEYR 65
GD C +PC + +C C+CL G G R C D+ DC
Sbjct: 2 GDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQF------- 54
Query: 66 CVDVCAGQCGVNSECNVRNHIPVCSCPPGYT 96
C+ + VCSC GYT
Sbjct: 55 --------------CHEEQNSVVCSCARGYT 71
>pdb|4D90|A Chain A, Crystal Structure Of Del-1 Egf Domains
pdb|4D90|B Chain B, Crystal Structure Of Del-1 Egf Domains
Length = 143
Score = 28.5 bits (62), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 32/94 (34%), Positives = 39/94 (41%), Gaps = 13/94 (13%)
Query: 169 NPCASGA-CAPTAQCEVRNHRAVCSCPVGYLGDPYTSCRAECLAHSDCPTDRPSCLGNKC 227
NPC +G C P + + C CP G+ DP S E + + PT C N C
Sbjct: 6 NPCENGGICLPG----LADGSFSCECPDGFT-DPNCSSVVEVASDEEEPTSAGPCTPNPC 60
Query: 228 MNPCAGQCGINAKCEVRGATPI---CSCPRDMTG 258
N G C I+ RG T I C CPR G
Sbjct: 61 HN--GGTCEISEA--YRGDTFIGYVCKCPRGFNG 90
>pdb|1S78|A Chain A, Insights Into Erbb Signaling From The Structure Of The
Erbb2- Pertuzumab Complex
pdb|1S78|B Chain B, Insights Into Erbb Signaling From The Structure Of The
Erbb2- Pertuzumab Complex
pdb|3BE1|A Chain A, Dual Specific Bh1 Fab In Complex With The Extracellular
Domain Of Her2ERBB-2
pdb|3MZW|A Chain A, Her2 Extracelluar Region With Affinity Matured 3-Helix
Affibody Zher2:342
pdb|3N85|A Chain A, Crystallographic Trimer Of Her2 Extracellular Regions In
Complex With Tryptophan-Rich Antibody Fragment
Length = 624
Score = 27.7 bits (60), Expect = 9.6, Method: Compositional matrix adjust.
Identities = 31/125 (24%), Positives = 41/125 (32%), Gaps = 26/125 (20%)
Query: 190 VCSCPVGYLGDPYTSCRAECLAHSDCPTDRPSCLG-NKCMNPCAGQC---GINAKCEVRG 245
V +CP YL SC C H+ T KC PCA C G+ EVR
Sbjct: 274 VTACPYNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRA 333
Query: 246 AT---------------PICSCPRDMTGDPFVRCRPFDKYVAPLINDYLKIYWRYQNNKT 290
T + P GDP APL + L+++ +
Sbjct: 334 VTSANIQEFAGCKKIFGSLAFLPESFDGDP-------ASNTAPLQPEQLQVFETLEEITG 386
Query: 291 IFYVS 295
Y+S
Sbjct: 387 YLYIS 391
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.322 0.139 0.502
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 13,170,492
Number of Sequences: 62578
Number of extensions: 604115
Number of successful extensions: 1418
Number of sequences better than 100.0: 98
Number of HSP's better than 100.0 without gapping: 33
Number of HSP's successfully gapped in prelim test: 65
Number of HSP's that attempted gapping in prelim test: 1188
Number of HSP's gapped (non-prelim): 262
length of query: 365
length of database: 14,973,337
effective HSP length: 100
effective length of query: 265
effective length of database: 8,715,537
effective search space: 2309617305
effective search space used: 2309617305
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 52 (24.6 bits)